![](/img/cover-not-exists.png)
1850 Safety of everolimus plus exemestane in elderly patients with Hormone-Receptor-Positive (HR+), HER2- locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors (NSAIs): BALLET (CRAD001YIC04)
Neven, P., Generali, D., Ciruelos, E.M., Lang, I., Gavila, J.G., Bighin, C., Borms, M., Conte, P., Montemurro, F., Sartori, D., Lee, T.V., Camozzi, M., Lorizzo, K., Ocak, O., Jerusalem, G.Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)30800-0
Date:
September, 2015
File:
PDF, 60 KB
english, 2015